Maspin has been shown to inhibit tumor cell invasion and metastasis in brea
st tumor cells. Maspin expression was detected in normal breast and prostat
e epithelial cells, whereas tumor cells exhibited reduced or no expression.
However, the regulatory mechanism of maspin expression remains unknown. We
report here a rapid and robust induction of maspin expression in prostate
cancer cells (LNCaP, DU145, and PC3) and breast tumor cells (MCF7) followin
g wild type p53 expression from an adenovirus p53 expression vector (AdWTp5
3). p53 activates the maspin promoter by binding directly to the p53 consen
sus-binding site present in the maspin promoter. DNA-damaging agents and cy
totoxic drugs induced endogenous maspin expression in cells containing the
wild type p53, Maspin expression was refractory to the DNA-damaging agents
in cells containing mutant p53, These results, combined with recent studies
of the tumor metastasis suppressor gene KAI1 and plasminogen activator inh
ibitor 1 (PAI1), define a new category of molecular targets of p53 that hav
e the potential to negatively regulate tumor invasion and/or metastasis.